PROCEPT BioRobotics (PRCT) Notes Payables (2023 - 2025)

PROCEPT BioRobotics (PRCT) has reported Notes Payables for 3 consecutive years, with $2.0 million the latest figure, recorded in Q1 2025.

• On a quarterly basis, Notes Payables rose 4.49% year-over-year to $2.0 million in Q1 2025; TTM through Mar 2025 was $2.0 million, a 4.49% increase from a year earlier, with the FY2024 full-year figure at $2.0 million, up 6.04% from the prior year.
• Notes Payables was $2.0 million for Q1 2025 at PROCEPT BioRobotics, roughly flat from $2.0 million in the prior quarter.
• Over five years, Notes Payables peaked at $2.0 million in Q3 2024 and troughed at $1.9 million in Q4 2023.
• A 3-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables gained 6.04% in 2024 and advanced 4.49% in 2025, its largest moves.
• Over 3 years, Notes Payables stood at $1.9 million in 2023, then gained by 6.04% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
• The last three Notes Payables figures came in at $2.0 million (Q1 2025), $2.0 million (Q4 2024), and $2.0 million (Q3 2024), per Business Quant data.